Related trials
SPIRIT IV, 2010 - everolimus eluting stent vs paclitaxel eluting stent
BASKET-PROVE (SES), 2010 - sirolimus eluting stent vs bare-metal stent
GISSOC II, 2010 - sirolimus eluting stent vs bare-metal stent
SORT-OUT-3, 2010 - zotarolimus eluting stent vs sirolimus eluting stent
RESOLUTE, 2010 - zotarolimus eluting stent vs everolimus eluting stent
BASKET-PROVE (EES), 2010 - everolimus eluting stent vs bare-metal stent
TRIANA, 2009 - primary ballon angioplasty vs tenecteplase
DEBATER (SES vs BMS), 2009 - sirolimus eluting stent vs bare-metal stent
ISAR TEST 2 (vs SES), 2009 - dual sirolimus, probucol eluting stent vs sirolimus eluting stent
ZEST (vs PES), 2009 - zotarolimus eluting stent vs paclitaxel eluting stent
ISAR-LEFT-MAIN, 2009 - sirolimus eluting stent vs paclitaxel eluting stent
NORDISTEMI, 2009 - thrombolysis + angioplasty vs immediate thrombolysis
ISAR TEST 3 (BP), 2009 - sirolimus biodegradable polymer vs sirolimus eluting stent
COMPARE, 2009 - everolimus eluting stent vs paclitaxel eluting stent
ENDEAVOR IV, 2009 - zotarolimus eluting stent vs paclitaxel eluting stent
Juwana, 2009 - sirolimus eluting stent vs paclitaxel eluting stent
GENIUS-STEMI, 2009 - Genous stent vs bare-metal stent
ZEST AMI (vs PES), 2009 - zotarolimus eluting stent vs paclitaxel eluting stent
ISAR-TEST-4 (biodegradable polymer), 2009 - sirolimus biodegradable polymer vs sirolimus eluting stent
ZEST (vs SES), 2009 - zotarolimus eluting stent vs sirolimus eluting stent
PASEO, 2009 - drug-eluting stents vs bare-metal stent
ISAR TEST 3 (PF), 2009 - polymer free sirolimus stent vs sirolimus eluting stent
ISAR TEST 2 (vs ZES), 2009 - dual sirolimus, probucol eluting stent vs zotarolimus eluting stent
Thiele, 2009 - sirolimus ES vs MIDCAB
ZEST AMI (vs SES), 2009 - zotarolimus eluting stent vs sirolimus eluting stent
See also:
All coronary artery disease clinical trials
All acute myocardial infarction clinical trials
All clinical trials of PCI
All clinical trials of drug-eluting stents
|
|
Treatments
Studied treatment |
paclitaxel-eluting stents and sirolimus-eluting stents
|
Control treatment |
bare metal stent
|
Concomittant treatment |
aspirin, clopidogrel 300 mg, unfractionated heparin 70 U/kg, upstream glycoprotein IIb/IIIa inhibitor. |
Remarks |
3 arms : SES, PES, BM |
Patients
Patients |
patients with ST-elevation myocardial infarction within 12 hours from symptom onset |
Exclusion criteria |
active internal bleeding or bleeding disorder within the last month; history of intracranial hemorrhage, intracranial neoplasm, arteriovenous malformation, or aneurysm; allergy to one of the study medications; history of stroke within the last month; history of surgical procedure or trauma within the last month; aortic dissection; fibrinolytic therapy within the previous 24 hours; thrombocytopenia; hemorrhagic retinopathy; currently taking warfarin; pregnancy
|
Baseline characteristics |
age |
62 y |
diabetes (%) |
26% |
Female (%) |
29% |
STEMI |
100% |
|
Method and design
Randomized effectives |
180 / 90 (studied vs. control) |
Design |
Parallel groups |
Blinding |
open |
Follow-up duration |
4.3 years |
Lost to follow-up |
0% |
Primary endpoint |
TLR 1 year |
Results
No results available for this trial
- no clinical endpoint reported
Meta-analysis of all similar trials:
Drug eluting stent in coronary artery disease for all type of patients
Drug eluting stent in coronary artery disease for acute myocardial infarction
myocardial revascularization in acute myocardial infarction for all type of patients
PCI in acute myocardial infarction for all type of patients
Reference(s)
-
Di Lorenzo E, De Luca G, Sauro R, Varricchio A, Capasso M, Lanzillo T, Manganelli F, Mariello C, Siano F, Pagliuca MR, Stanco G, Rosato G.
The PASEO (PaclitAxel or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty) Randomized Trial..
JACC Cardiovasc Interv 2009 Jun;2:515-23
Pubmed
|
Hubmed
| Fulltext
-
Di Lorenzo E, Sauro R, Varricchio A, Carbone G, Cortese G, Capasso M, Lanzillo T, Manganelli F, Mariello C, Siano F, Pagliuca MR, Stanco G, Rosato G, De Luca G.
Long-Term outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in Primary Angioplasty (PASEO) Randomized Trial..
Circulation 2009;120:964-72
Pubmed
|
Hubmed
| Fulltext
|